Underwater removal of small gastric neuroendocrine tumors
Part of Cancer, Digestive system clinical trials.
This trial tests a special underwater technique to remove small type I gastric neuroendocrine tumors (5-9 mm) during an endoscopy. The goal is to see if it is safe and effective, which could offer a less invasive treatment option.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have a small (5-9 mm) type I gastric neuroendocrine tumor seen during an endoscopy
- You are healthy enough for an endoscopic procedure and sedation
- The tumor does not show signs of deep invasion or other high-risk features
- You agree to the procedure by signing a consent form
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether using a special traction device during endoscopic removal of small rectal neuroendocrine tumors is safer or more effective than the standard method. It may help patients with these tumors have a less invasive treatment.
This study is testing whether a minimally invasive endoscopic procedure (using a scope through the anus) can safely remove small rectal neuroendocrine tumors. If you're eligible, this could be a less invasive way to treat your condition without major surgery.
This trial studies two ways to remove small rectal neuroendocrine tumors (slow-growing tumors in the rectum) using an endoscope. It aims to see which method works better and if it can be done safely and effectively without more invasive surgery.
This study compares two ways of removing very small rectal neuroendocrine tumors (less than 1 cm): a modified technique using a special snare (mDS-EMR) versus a more involved removal called ESD. Both are done through a scope (endoscopy) without major surgery.
This study compares two minimally invasive ways to remove small rectal neuroendocrine tumors (NETs), which are growths in the rectum that are usually not cancer. The goal is to find which method is safer and more effective with fewer side effects.
This trial tests a robotic-assisted endoscope (a thin, flexible tube with a camera) to remove early-stage tumors from the stomach, colon, or rectum without major surgery. It aims to see if this new robotic method is safe and effective.
Hear when a new Stomach Neuroendocrine Neoplasm trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.